Paper Details

  1. Home
  2. Paper Details

Efficacy of Repeat Selective Laser Trabeculoplasty in Medication-Naive Open-Angle Glaucoma and Ocular Hypertension during the LiGHT Trial.

Author: , AmblerGareth, BartonKeith, BunceCatey, GargAnurag, Garway-HeathDavid, GazzardGus, KonstantakopoulouEvgenia, NathwaniNeil, VickerstaffVictoria, WormaldRichard

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Repeat selective laser trabeculoplasty (SLT) maintained intraocular pressure (IOP) at or below target IOP in medication-naive open-angle glaucoma (OAG) and ocular hypertensive (OHT) eyes requiring retreatment, demonstrating an equivalent duration of effect to initial laser.
Paper Details　
Original Abstract of the Article :
PURPOSE: To determine the efficacy of repeat selective laser trabeculoplasty (SLT) in medication-naive open-angle glaucoma (OAG) and ocular hypertensive (OHT) patients requiring repeat treatment for early to medium-term failure during the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. DES...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.ophtha.2019.10.023

データ提供：米国国立医学図書館（NLM）

Repeat SLT for Glaucoma and Ocular Hypertension: A Desert Oasis of Hope?

The field of ophthalmology is constantly searching for better ways to manage glaucoma and ocular hypertension. This research delves into the effectiveness of repeat selective laser trabeculoplasty (SLT) in patients who haven't yet started medications for these conditions. Imagine a desert oasis—that's how SLT works! It provides a refreshing relief to the pressure buildup in the eye, giving those suffering from glaucoma and ocular hypertension a chance to maintain their vision. The study used a prospective randomized controlled trial and looked at patients who needed repeat SLT treatment within 18 months. It analyzed the data to see if repeat SLT was as effective as the initial treatment in lowering eye pressure over a long period.

Repeat SLT: A Second Bloom in the Desert

The researchers discovered that repeat SLT was indeed effective in maintaining eye pressure at or below the target level for at least as long as the initial treatment. It's like a second bloom of a desert flower, bringing a fresh wave of relief! They found that 67% of the eyes in the study maintained good control of eye pressure after 18 months, and there were no significant side effects.

Repeat SLT for a Healthier Desert Oasis

This research suggests that repeat SLT can be a valuable tool for managing glaucoma and ocular hypertension in patients who haven't yet started medications. It offers a way to delay or potentially avoid the need for medications, which can be a significant benefit for many individuals. Of course, it's important to consult with an eye doctor to determine if repeat SLT is right for you.

Dr.Camel's Conclusion

Just like a desert oasis provides a vital source of water, repeat SLT offers a hopeful solution for those facing the challenges of glaucoma and ocular hypertension. It's a testament to the ongoing innovation in ophthalmology, providing new tools for managing these conditions and preserving sight.

Date :
  1. Date Completed 2020-06-18
  2. Date Revised 2020-06-18
Further Info :

Pubmed ID

32005561

DOI: Digital Object Identifier

10.1016/j.ophtha.2019.10.023

Related Literature

Article Analysis
・Effective treatment of glaucoma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.